PRMT5 silencing selectively affects MTAP ‐deleted mesothelioma: In vitro evidence of a novel promising approach
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PRMT5 silencing selectively affects
MTAP
‐deleted mesothelioma: In vitro evidence of a novel promising approach
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 24, Issue 10, Pages 5565-5577
Publisher
Wiley
Online
2020-04-17
DOI
10.1111/jcmm.15213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A patent review of arginine methyltransferase inhibitors (2010-2018)
- (2019) Xiao Li et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Role of protein arginine methyltransferase 5 in human cancers
- (2019) Wendi Xiao et al. BIOMEDICINE & PHARMACOTHERAPY
- Exploiting methionine restriction for cancer treatment
- (2018) Sushma Chaturvedi et al. BIOCHEMICAL PHARMACOLOGY
- Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment
- (2018) Marcella Barbarino et al. JOURNAL OF CELLULAR PHYSIOLOGY
- RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines
- (2018) Francesca Pentimalli et al. ONCOGENE
- Identification of a Novel Protein Arginine Methyltransferase 5 Inhibitor in Non-small Cell Lung Cancer by Structure-Based Virtual Screening
- (2018) Qianqian Wang et al. Frontiers in Pharmacology
- Surgery for malignant pleural mesothelioma: an international guidelines review
- (2018) Sara Ricciardi et al. Journal of Thoracic Disease
- Scientific Advances and New Frontiers in Mesothelioma Therapeutics
- (2018) Luciano Mutti et al. Journal of Thoracic Oncology
- Expressions and prognostic values of the E2F transcription factors in human breast carcinoma
- (2018) Ze-Long Liu et al. Cancer Management and Research
- Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth
- (2018) Shikui Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma
- (2017) Aya Shinozaki-Ushiku et al. HISTOPATHOLOGY
- E2F1 silencing inhibits migration and invasion of osteosarcoma cells via regulating DDR1 expression
- (2017) Zhaofeng Wang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting YAP in malignant pleural mesothelioma
- (2017) Wen-Qian Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- P3.03-005 Inhibition of PRMT5 is Synthetic Lethal in Mesotheliomas Harboring MTAP Loss
- (2017) Annabel Sharkey et al. Journal of Thoracic Oncology
- Role of protein arginine methyltransferase 5 in inflammation and migration of fibroblast-like synoviocytes in rheumatoid arthritis
- (2016) Dongying Chen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
- (2016) Gérard Zalcman et al. LANCET
- Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?
- (2016) Ewa M. Michalak et al. Molecular Oncology
- PRMT5–PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells
- (2016) Y K Banasavadi-Siddegowda et al. ONCOGENE
- Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5
- (2016) Konstantinos J. Mavrakis et al. SCIENCE
- MTAPdeletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
- (2016) Gregory V. Kryukov et al. SCIENCE
- MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
- (2016) Katya Marjon et al. Cell Reports
- Suppressive effects of tumor cell-derived 5′-deoxy-5′-methylthioadenosine on human T cells
- (2016) Frederik C. Henrich et al. OncoImmunology
- Implications of Genetic and Epigenetic Alterations of CDKN2A (p16 INK4a ) in Cancer
- (2016) Ran Zhao et al. EBioMedicine
- The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
- (2015) Nicole Stopa et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tremelimumab for the treatment of malignant mesothelioma
- (2015) Alice Guazzelli et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies
- (2015) Angela Bononi et al. Expert Review of Respiratory Medicine
- Roles of enhancer of zeste homolog 2: From skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis
- (2014) Irene Marchesi et al. CELL CYCLE
- Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition
- (2014) Reem Ibrahim et al. HUMAN PATHOLOGY
- Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro
- (2014) Xiaosi Han et al. JOURNAL OF NEURO-ONCOLOGY
- Clinical Significance of Epithelial-Mesenchymal Transition-Associated Markers in Malignant Pleural Mesothelioma
- (2014) Takashi Iwanami et al. ONCOLOGY
- Hydrogen Peroxide Promotes Epithelial to Mesenchymal Transition and Stemness in Human Malignant Mesothelioma Cells
- (2013) Myung-Chul Kim et al. Asian Pacific Journal of Cancer Prevention
- Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors
- (2013) Konstantin Shilo et al. Diagnostic Pathology
- PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1
- (2013) Giulia Pinton et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Overexpression of PRMT5 Promotes Tumor Cell Growth and Is Associated with Poor Disease Prognosis in Epithelial Ovarian Cancer
- (2013) Xiangxiang Bao et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Asbestos is not just asbestos: an unrecognised health hazard
- (2013) Francine Baumann et al. LANCET ONCOLOGY
- Arginine Methylation-Dependent Reader-Writer Interplay Governs Growth Control by E2F-1
- (2013) Shunsheng Zheng et al. MOLECULAR CELL
- PRMT5 Is Upregulated in Malignant and Metastatic Melanoma and Regulates Expression of MITF and p27Kip1
- (2013) Courtney Nicholas et al. PLoS One
- Passenger deletions generate therapeutic vulnerabilities in cancer
- (2012) Florian L. Muller et al. NATURE
- Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity
- (2011) Joseph R. Bertino et al. CANCER BIOLOGY & THERAPY
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Direct and tumor microenvironment mediated influences of 5′-deoxy-5′-(methylthio)adenosine on tumor progression of malignant melanoma
- (2008) Axel P. Stevens et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Quantitative analysis of 5′-deoxy-5′-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry
- (2008) Axel P. Stevens et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Advances in the systemic therapy of malignant pleural mesothelioma
- (2008) Dean A Fennell et al. Nature clinical practice. Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search